Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review. | Cells | 2023 | 37508529 | PubTator, text mining | PubMed |
| Emerging trends in IRAK-4 kinase research. | Mol Biol Rep | 2023 | 37490192 | PubTator, text mining | PubMed |
| Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier. | Antibodies (Basel) | 2023 | 37489365 | PubTator, text mining | PubMed |
| Advances and Prospects in the Treatment of Pancreatic Cancer. | Int J Nanomedicine | 2023 | 37489138 | PubTator, text mining | PubMed |
| COVID-19 annual update: a narrative review. | Hum Genomics | 2023 | 37488607 | PubTator, text mining | PubMed |
| Full-length transcript alterations in human bronchial epithelial cells with U2AF1 S34F mutations. | Life Sci Alliance | 2023 | 37487637 | PubTator, text mining | PubMed |
| Disulfiram blocks inflammatory TLR4 signaling by targeting MD-2. | Proc Natl Acad Sci U S A | 2023 | 37487070 | PubTator, text mining | PubMed |
| Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022. | Front Microbiol | 2023 | 37485519 | PubTator, text mining | PubMed |
| A critical evaluation of protein kinase regulation by activation loop autophosphorylation. | Elife | 2023 | 37470698 | PubTator, text mining | PubMed |
| Targeting transcription factors for therapeutic benefit in rheumatoid arthritis. | Front Immunol | 2023 | 37457726 | PubTator, text mining | PubMed |
| Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications. | Molecules | 2023 | 37446908 | PubTator, text mining | PubMed |
| The Evolutionary Scenario of Pediatric Unclassified Primary Antibody Deficiency to Adulthood. | J Clin Med | 2023 | 37445241 | PubTator, text mining | PubMed |
| Secondary-Type Mutations in Acute Myeloid Leukemia: Updates from ELN 2022. | Cancers (Basel) | 2023 | 37444402 | PubTator, text mining | PubMed |
| Pulmonary interleukin 1 beta/serum amyloid A3 axis promotes lung metastasis of hepatocellular carcinoma by facilitating the pre-metastatic niche formation. | J Exp Clin Cancer Res | 2023 | 37443052 | PubTator, text mining | PubMed |
| Sufu limits sepsis-induced lung inflammation via regulating phase separation of TRAF6. | Theranostics | 2023 | 37441604 | PubTator, text mining | PubMed |
| When the allergy alarm bells toll: The role of Toll-like receptors in allergic diseases and treatment. | Front Mol Biosci | 2023 | 37426425 | PubTator, text mining | PubMed |
| Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review. | Exp Hematol Oncol | 2023 | 37422676 | PubTator, text mining | PubMed |
| Synthesis and evaluation of dihydrofuro[2,3-b]pyridine derivatives as potent IRAK4 inhibitors. | Eur J Med Chem | 2023 | 37413880 | PubTator, text mining | PubMed |
| The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases. | Eur J Med Chem | 2023 | 37402343 | PubTator, text mining | PubMed |
| Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies. | Dermatol Ther (Heidelb) | 2023 | 37402031 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=18